<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) is an aggressive non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo> characterized by specific morphological and immunophenotypic features </plain></SENT>
<SENT sid="1" pm="."><plain>The basic genetic feature of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> is the rearrangement of MYC gene, visible as t(8;14)(q24;q32) translocation or its variant </plain></SENT>
<SENT sid="2" pm="."><plain>However, some <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with characteristic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> <z:mp ids='MP_0000002'>morphology</z:mp> are nowadays diagnosed as B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> unclassifiable with features intermediate between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> (Inter-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) for biological or clinical reasons </plain></SENT>
<SENT sid="3" pm="."><plain>We present four <z:hpo ids='HP_0002665'>lymphomas</z:hpo> without the MYC rearrangement presented typical Burkitt <z:mp ids='MP_0000002'>morphology</z:mp>, FCM immunophenotype with some deviations when compared to a typical <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The cases were finally diagnosed as Inter-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of them presented a recurrent abnormality within the chromosome 11: dup(11)(q23q13) </plain></SENT>
<SENT sid="6" pm="."><plain>We suppose that the dup(11)(q23q13), in absence of the MYC gene rearrangement, is connected with borderline <z:hpo ids='HP_0002665'>lymphomas</z:hpo> with a <z:mp ids='MP_0000002'>morphology</z:mp> similar or identical to that of the Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Identifying such an aberration may be helpful in the diagnostics of Inter-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> eventually forming a distinct subgroup of <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>